News
Eli Lilly Shares Up 13% After Weight Loss Pill Appears As Effective As Ozempic And Mounjaro In Trials
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily weight loss pill, orforglipron, demonstrated effectiveness consistent with other injectable GLP-1 weight loss drugs, such as Lilly’s Mounjaro and Novo Nordisk’s Ozempic.
Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...
Patients on the new pill also lost weight — up to 16 pounds without reaching a plateau at the study’s end. Side effects were ...
A new weight-loss pill taken daily could compete with injections like Ozempic, research suggests. Patients, who all were ...
Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...
Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert ...
Novo Nordisk, the maker of Ozempic and Wegovy, has also jumped into the legal fight —this time by intervening in the OFA’s lawsuit against the FDA. The company supports the agency’s move to restrict ...
Meghan Trainor said she’s been taking Mounjaro for weight loss alongside her husband, ‘Spy Kids’ actor Daryl Sabara. The ...
The India launch of Eli Lilly's Mounjaro in India has triggered a huge wave of enquiries from those looking for its ...
A STUDENT nurse is one step closer to her dream of having a baby after shedding 115lbs on Mounjaro. Laurie Murray, from Airdrie, started using the weight loss jabs last April when she tipped the ...
A study found that medicines marketed as Zepbound and Mounjaro can help people lose weight for up to three years.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback